We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 335

U.S. Supreme Court Myriad decision not expected to affect Australian law-makers

  • Houlihan2
  • -
  • Australia, USA
  • -
  • June 14 2013

The U.S. Supreme Court has this week invalidated Myriad's Patent on isolated DNA of the BRCA-1 gene and its use in their breast cancer diagnostic

The Centre for International Economics publishes report on gene patents

  • Watermark Patent & Trade Marks Attorneys
  • -
  • Australia
  • -
  • June 14 2013

A report entitled 'Economic Analysis of the Impact of Isolated Human Gene Patents', produced by The Centre for International Economics (CIE) on

US Supreme Court: naturally occurring DNA not patentable but cDNA is patenable

  • Phillips Ormonde Fitzpatrick
  • -
  • Australia
  • -
  • June 14 2013

Overnight, the United States Supreme Court has ruled that a naturally occurring DNA segment is a product of nature and not patent eligible merely

US Supreme Court rules isolated DNA lacks patent eligibility

  • Wrays
  • -
  • Australia, USA
  • -
  • June 14 2013

On 13 June 2013, the United States Supreme Court ruled in Association for Molecular Pathology v. Myriad Genetics ("Myriad") that: For the reasons

The US Supreme Court rules on gene patents

  • Shelston IP
  • -
  • Australia, USA
  • -
  • June 14 2013

In its long-awaited landmark decision in the case of Association for Molecular Pathology v. Myriad Genetics Inc., the U.S. Supreme Court has

The difference a letter can make

  • Norton Rose Australia
  • -
  • Australia
  • -
  • June 13 2013

In an effort to avoid confusion, the World Health Organisation designates a generic name, or International Non-proprietary Name (INN), for each

Gene patents: apparently we are missing the point

  • Watermark Patent & Trade Marks Attorneys
  • -
  • Australia
  • -
  • June 13 2013

I recently blogged on the topic of gene patents in light of news publicising Angelina Jolie's pre-emptive actions in dealing with her increased risks

The economics of isolated human gene patents in Australia

  • Shelston IP
  • -
  • Australia
  • -
  • June 13 2013

On the basis of the recommendations of the 2010 Senate Community Affairs References Committee Report on Gene Patents, the Centre for International

In vitro results may lack sufficiency to protect in vivo applications - balancing deadlines for projects, patents and profit

  • Houlihan2
  • -
  • Australia
  • -
  • June 7 2013

Maintaining and driving commercial success in the current economic climate, particularly in the ChemicalBiotechnologicalLife Sciences sectors

A Kiwi-sized spanner in the works of the TPP?

  • Shelston IP
  • -
  • Asia-Pacific, Australia, New Zealand
  • -
  • June 7 2013

We have previously reported on progress toward the Trans-Pacific Partnership ("TPP") - a Free Trade Agreement ("FTA") presently under negotiation by

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy